This trialwill compare how well two drugs prevent urinary retention after surgery.
- Postoperative Urinary Retention
1 Primary · 3 Secondary · Reporting Duration: At discharge (up to 365 days)
Awards & Highlights
2 Treatment Groups
1 of 2
1 of 2
140 Total Participants · 2 Treatment Groups
Primary Treatment: Sugammadex · No Placebo Group · Phase 3
Who is running the clinical trial?
Age 18+ · All Participants · 0 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
How many participants are being accepted into this research project?
"The information available on clinicaltrials.gov does show that this study is looking for willing participants. The study was originally posted on April 13th, 2022 and updated as recently as October 28th, 2022. Currently, there is a goal to enroll 140 patients at a single site." - Anonymous Online Contributor
What are the government regulations surrounding Sugammadex?
"This medication has received a score of 3 from our team at Power, meaning that it is considered safe. This is because Sugammadex is a Phase 3 trial, which means that there is some data supporting its efficacy and multiple rounds of data supporting its safety." - Anonymous Online Contributor
Are there any volunteers still needed for this experiment?
"Yes, this is accurate. The clinical trial in question is still looking for participants, as can be seen on clinicaltrials.gov. The trial was first posted on April 13th, 2022 and was last updated on October 28th, 2022." - Anonymous Online Contributor